Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Khiron Life Sciences (KHRN) stocks in Canada

Learn how to easily invest in Khiron Life Sciences stocks.

Khiron Life Sciences is a drug manufacturers-specialty & generic business based in Canada. Khiron Life Sciences stocks (KHRN.V) are listed on the V and all prices are listed in Canadian Dollars. Its last market close was C$0.24 – a decrease of 9.52% over the previous week. Khiron Life Sciences employs 0 staff and has a trailing 12-month revenue of around C$11.7 million.

How to buy shares in Khiron Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KHRN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Khiron Life Sciences stock price (V:KHRN)

Use our graph to track the performance of KHRN stocks over time.

Khiron Life Sciences shares at a glance

Information last updated 2022-01-24.
Latest market closeC$0.19
52-week rangeC$0.17 - C$0.76
50-day moving average C$0.22
200-day moving average C$0.33
Wall St. target priceC$0.87
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) C$-0.11

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Khiron Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Khiron Life Sciences price performance over time

Historical closes compared with the close of C$0.19 from 2022-01-27

1 week (2022-01-21) -9.52%
1 month (2021-12-24) -9.52%
3 months (2021-10-28) -28.30%
6 months (2021-07-28) -40.63%
1 year (2021-01-28) -47.22%
2 years (2020-01-28) -80.61%
3 years (2019-01-28) 2.05
5 years (2017-01-24) N/A

Khiron Life Sciences financials

Revenue TTM C$11.7 million
Gross profit TTM C$7 million
Return on assets TTM -16.57%
Return on equity TTM -30.14%
Profit margin -137.04%
Book value C$0.31
Market capitalisation C$35.8 million

TTM: trailing 12 months

Khiron Life Sciences share dividends

We're not expecting Khiron Life Sciences to pay a dividend over the next 12 months.

Have Khiron Life Sciences's shares ever split?

Khiron Life Sciences's shares were split on a 1:8 basis on 24 May 2018. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Khiron Life Sciences shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Khiron Life Sciences shares which in turn could have impacted Khiron Life Sciences's share price.

Khiron Life Sciences share price volatility

Over the last 12 months, Khiron Life Sciences's shares have ranged in value from as little as C$0.165 up to C$0.76. A popular way to gauge a stock's volatility is its "beta".

KHRN.V volatility(beta: 1.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (V average) beta is 1, while Khiron Life Sciences's is 1.9505. This would suggest that Khiron Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Khiron Life Sciences overview

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. is based in Vancouver, Canada.

Stocks similar to Khiron Life Sciences

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site